SpyBiotech
Biotech services company
SpyBiotech has raised €31M across 2 funding rounds from 2 investors, most recently a Series A round in Feb 2021. Based in Oxford, UK; active in Healthtech. Data as of 4 Nov 2026.
Oxford, UKspybiotech.com ↗
Total raised
€31M
€31,452,629
Funding rounds
2
Investors
2
distinct backers
Active since
2017-03
latest 2021-02
Funding by year
EUR raised per yearSpyBiotech — funding by year — interactive chart.
Data table
| SpyBiotech — funding by year | |
|---|---|
| 2017 | €4.6M |
| 2021 | €27M |
Signals
High confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood9
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 9y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-02-11 | Series A | €27M | Braavos Capital | View deal → |
| 2017-03-31 | Other | €4.6M | GV (Google Ventures) | View deal → |
Investors
2Related news
Similar companies
same sector, similar size- Manual€31MUK · Healthtech
- Lottie€31MUK · Healthtech
- Nucleome Therapeutics€38MUK · Healthtech
- MiNA Therapeutics€25MUK · Healthtech
- Adendra Therapeutics€47MUK · Healthtech
- Zava€28MUK · Healthtech
Global coverage: FundingData